Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Bariatric surgery shows metabolic benefits in lower-BMI patients

Publish date:: November 7, 2019

Key clinical point: Patients derived metabolic benefits from bariatric surgery even when their baseline body mass index was lower than 35 kg/m2.

Major finding: Discontinuation of hypertension drugs occurred in 60% of patients with lower BMIs at baseline and 54% of those with higher BMIs.

Study details: Review of prospectively collected data from 45,584 patients who underwent sleeve gastrectomy in Michigan during 2006-2018.

Disclosures: The study received no commercial funding. Dr. Varban receives salary support from Blue Cross Blue Shield of Michigan. Dr. Misra had no relevant disclosures.

Citation:

Varban OA et al. Obesity Week 2019, Abstract A105.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Obesity

Endoscopic intragastric balloon improved NASH parameters,

Autologous fecal microbiota transplantation helped maintain weight loss after ‘green’ Mediterranean diet,

Obesity phenotyping matches patients with more effective interventions,

Bariatric surgery linked to longer life,

Psychosocial resilience associated with better cardiovascular health in Blacks,